ST Pharm Co.,Ltd. (237690.KQ) News
Follow ST Pharm Co.,Ltd. (237690.KQ) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
ST Pharm's HIV drug candidate STP0404 shows viral load reduction in Phase 2a trial
ST Pharm's Phase 2a trial for HIV-1 drug candidate STP0404 showed antiviral activity versus placebo and a generally favorable safety and tolerability profile. Final clinical study report received Oct. 3, 2026.
EQUITY | Oct 06, 2026, 05:55 AM UTC
L
BRIEF — St Pharm Wins 91.3 Billion Won Order
ST Pharm Co Ltd: St Pharm: Wins 91.3 Billion Won Order Source text:... Further company coverage: 237690.KQ
NEWS | Sep 18, 2026, 05:32 AM UTC